Novel assays to assess the prevalence and neutralizing potential of anti-IdeS antibodies in healthy humans
BackgroundThe IgG-degrading enzyme IdeS (imlifidase) is a cysteine protease produced by Streptococcus pyogenes. It specifically hydrolyzes human IgG, cleaving the molecule to separate the F(ab’)2 fragment from the Fc region, thereby promoting IgG catabolism. The therapeutic form of IdeS (Idefirix®)...
Gardado en:
| Principais autores: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2026-02-01
|
| Series: | Frontiers in Immunology |
| Assuntos: | |
| Acceso en liña: | https://www.frontiersin.org/articles/10.3389/fimmu.2026.1728855/full |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|